Global Healthcare Analyst

Tina Banerjee

Equity research analyst having 15+ years of experience, with an interest on fundamentally strong global healthcare companies. I have been helping investors to find future winners in healthcare space to grow their wealth by focusing on the strength and potential of the business models of the companies. My initiating coverage reports and pitch help investors to know ‘what to buy’, ‘why to buy’, and ‘when to buy’. My clients always remain on top of the sector with the help of my timely and detailed notes on earnings or any news update. I also provide broader view on the entire healthcare sector through periodic thematic reports.

Equity Capital Markets

<ul>
<li>Lingyi iTech launched its Hongkong IPO aiming to raise up to HK$8.3B (~ US$ 1.1B). They are are a leading high-precision intelligent manufacturing platform for electronic devices.  </li>
<li>Lingyi iTech intends to use the IPO proceeds for expanding production facilities, scale overseas infrastructure, investment &amp; acquisition opportunities, enhance R&amp;D capabilities and working capital.</li>
<li>We would recommend investors with a near to medium-term investment horizon to consider the name, given the scale and prospects.</li>
</ul>


Lingyi iTech launched its Hongkong IPO aiming to raise up to HK$8.3B (~ US$ 1.1B). They are are a leading high-precision intelligent manufacturing platform for electronic devices.  
Lingyi iTech intends to use the IPO proceeds for expanding production facilities, scale overseas infrastructure, investment &amp; acquisition opportunities, enhance R&amp;D capabilities and working capital.
We would recommend investors with a near to medium-term investment horizon to consider the name, given the scale and prospects.


Shenzhen FRD Science & Technol (300602 CH)

Chipsea Technologies (Shenzhen) (688595 CH)

Lingyi ITech IPO: Business Model, Operational Scale and Valuation Works Out For Investors, For Now